Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | PPARD | Q03181 | 4/20 | 0.49 |
| ▸ | PPARA | Q07869 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | F7 | P08709 | 4/20 | 0.49 |
| ▸ | F3 | P13726 | 4/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | FABP4 | P15090 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6746429 | 1.00 | TRPV1 (0.53) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL7035466 | 1.00 | TRPV1 (0.53) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL30767690 | 0.98 | TRPV1 (0.52) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL1891215 | 0.98 | TRPV1 (0.52) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL14177977 | 0.98 | TRPV1 (0.52) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL7034321 | 0.92 | FAAH (0.52) | TRPV1PPARGPPARDPPARAF7 | |
| SCHEMBL37878 | 0.92 | FAAH (0.52) | TRPV1PPARGPPARDPPARAF7 | |
| SCHEMBL7032782 | 0.92 | FAAH (0.52) | TRPV1PPARGPPARDPPARAF7 | |
| SCHEMBL22578571 | 0.92 | FAAH (0.52) | TRPV1PPARGPPARDPPARAF7 | |
| SCHEMBL1066415 | 0.92 | FAAH (0.52) | TRPV1PPARGPPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753496-B2 | Softening composition | COATEX (FR) | 2023-09-12 | — | — | US | disclosed |
| CN-111433245-B | Softening composition | 可泰克斯公司 | 2022-12-20 | — | — | CN | disclosed |
| EP-3728376-A1 | SOFTENING COMPOSITION | Coatex (FR) | 2020-10-28 | — | — | EP | disclosed |
| US-20200277431-A1 | SOFTENING COMPOSITION | COATEX (FR) | 2020-09-03 | — | — | US | disclosed |
| CN-111433245-A | Softening composition | 可泰克斯公司 | 2020-07-17 | — | — | CN | disclosed |
| US-20040122089-A1 | Analogs of andandamide and arvanil have been found to act at receptors; are useful in pain management, used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277431-A1 | SOFTENING COMPOSITION | KRT18, DSG1, XRCC6 | TRPV1 2750/4885PPARG 4221/4885ALDH1A1 4233/4885 |
| US-11753496-B2 | Softening composition | KRT18, DSG1, XRCC6 | TRPV1 2750/4885PPARG 4221/4885ALDH1A1 4233/4885 |
| US-20040122089-A1 | Analogs of andandamide and arvanil have been found to act at receptors; are useful in pain management, used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications | CNR1, AVPR1A, OPRL1 | TRPV1 4/4885PPARG 2750/4885ALDH1A1 702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.